Phase III Comparison of Adjuvant Chemotherapy W/High-Dose Cyclophosphamide Plus Doxorubicin (AC) vs Sequential Doxorubicin Fol by Cyclophosphamide (A-C) in High Risk Breast Cancer Patients With 0-3 Positive Nodes (Intergroup, CALGB 9394)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: High Risk|Breast Cancer|Positive Nodes|Cyclophosphamide|Doxorubicin
Interventions: DRUG: Doxorubicin|DRUG: Cyclophosphamide|DRUG: G-CSF|DRUG: tamoxifen|DRUG: ciprofloxacin
Sponsor: National Cancer Institute (NCI)
Collaborators: Cancer and Leukemia Group B